Anti-NEK9 antibody [EP7361]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Recombinant Monoclonal NEK9 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse, Rat, Human samples. Cited in 14 publications.
View Alternative Names
KIAA1995, NEK8, NERCC, NEK9, Serine/threonine-protein kinase Nek9, Nercc1 kinase, Never in mitosis A-related kinase 9, NimA-related kinase 8, NimA-related protein kinase 9, Nek8
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-NEK9 antibody [EP7361] (AB138488)
Immunofluorescent analysis of HeLa cells labelling NEK9 with unpurified ab138488 at 1/250 dilution.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-NEK9 antibody [EP7361] (AB138488)
Intracellular Flow Cytometry analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling Sonic Hedgehog with purified ab53281 at 1/20 dilution (10 ug/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - cells without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NEK9 antibody [EP7361] (AB138488)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labelling NEK9 with unpurified ab138488 at 1/50 dilution.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NEK9 antibody [EP7361] (AB138488)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human testis tissue sections labeling NEK9 with Purified ab138488 at 1 : 100 dilution (3.84 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-NEK9 antibody [EP7361] (AB138488)
Immunocytochemistry/ Immunofluorescence analysis of NIH/3T3 (Mouse embryonic fibroblast) cells labeling NEK9 with Purified ab138488 at 1 : 100 dilution (3.8μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- WB
Lab
Western blot - Anti-NEK9 antibody [EP7361] (AB138488)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-NEK9 antibody [EP7361] (ab138488) at 1/5000 dilution
Lane 1:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 15 µg
Lane 2:
THP-1 (Human monocytic leukemia monocyte) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 107 kDa
Observed band size: 120 kDa
false
- WB
Lab
Western blot - Anti-NEK9 antibody [EP7361] (AB138488)
Lanes 1 - 4 : Merged signal (red and green). Green - ab138488 observed at 120 kDa. Red - loading control, ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55kDa.
ab138488 was shown to react with NEK9 in wild-type A431 cells in western blot. Loss of signal was observed when NEK9 knockout sample was used. Wild-type and NEK9 knockout A431 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab138488 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-NEK9 antibody [EP7361] (ab138488) at 1/1000 dilution
Lane 1:
Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
NEK9 knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human NEK9 knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-nek9-knockout-a-431-cell-line-ab270474'>ab270474</a>)
Lane 3:
Hep G2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Predicted band size: 107 kDa
Observed band size: 120 kDa
false
- WB
Lab
Western blot - Anti-NEK9 antibody [EP7361] (AB138488)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-NEK9 antibody [EP7361] (ab138488) at 1000 Cells
All lanes:
Rat spleen lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 107 kDa
Observed band size: 120 kDa
false
- WB
Unknown
Western blot - Anti-NEK9 antibody [EP7361] (AB138488)
All lanes:
Western blot - Anti-NEK9 antibody [EP7361] (ab138488) at 1/1000 dilution
Lane 1:
NIH3T3 cell lysate at 10 µg
Lane 2:
HepG2 cell lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Lane 4:
THP1 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 107 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein modulates different aspects of mitosis particularly in spindle formation and chromosome segregation. NEK9 forms a part of a complex in conjunction with other kinases like NEK6 and NEK7 coordinating the early events of mitosis. Its activity supports centrosome separation and microtubule nucleation which are important for proper cell division.
Pathways
NEK9 is involved in the cell cycle and microtubule organization pathways. It works in conjunction with proteins such as PLK1 and Aurora A which regulate the entry and progression through mitosis. NEK9 activates NEK6 and NEK7 which further propagate signals necessary for mitotic spindle assembly ensuring efficient cell division.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 14:421 PubMed37443302
2023
Applications
Unspecified application
Species
Unspecified reactive species
FEBS letters 597:1290-1299 PubMed36776133
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:870 PubMed36797266
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:342 PubMed36611072
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 208:2029-2036 PubMed35354613
2022
Applications
Unspecified application
Species
Unspecified reactive species
Current research in chemical biology 1: PubMed40837099
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 133: PubMed32184261
2020
Applications
Unspecified application
Species
Unspecified reactive species
Pathology 52:329-335 PubMed32098687
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 295:1240-1260 PubMed31857374
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 9:2330 PubMed29899413
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com